ADCendo

ADCendo

A Copenhagen-based biotech company dedicated to developing highly differentiated antibody-drug conjugates (ADCs) for the treatment of underserved cancers. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD434m (Public information from May 2024)
Company register number 38780093
Copenhagen Capital Region of Denmark (HQ)
Authorizing premium user...